Keyword: GlaxoSmithKline (GSK)
News
28.05.2013
- AstraZeneca is to buy Omthera Pharmaceuticals for as much as $443 million to build up its cardiovascular drug business, a priority area for Britain's second-biggest drugmaker. The...
News
23.05.2013
- Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the...
News
22.05.2013
- The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and bioterrorism. The...
News
13.05.2013
- Elan stepped up its bid to keep its independence on Monday by agreeing a $1 billion deal to buy 21% of the royalties that U.S. company Theravance receives from GlaxoSmithKline for...
News
07.05.2013
- A new generation of drug industry chief executives is stepping up plans to restructure their businesses by divesting slower-growing and maturing operations, opening up new...
News
03.05.2013
- Is nanomedicine the next big thing? A growing number of top drug companies seem to think so. The ability to encapsulate potent drugs in tiny particles measuring billionths of a...
News
25.04.2013
- GlaxoSmithKline is to sell soft drink brands Lucozade and Ribena in a move analysts believe will raise over 1 billion pounds ($1.5 billion) and focus its consumer health business...
News
23.04.2013
- Britain has blocked efforts by oil major Royal Dutch Shell to settle a $2.3 billion debt it owes Iran by paying in kind with grains or pharmaceuticals, industry sources said. Shell...
